To Evaluate Pharmacokinetics and Safety of Two Different Formulation of Rebamipide in Healthy Volunteers

NCT04150172 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

40

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy Volunteers

Interventions

DRUG: Rebamipide SR 150mg
DRUG: Rebamipide IR 100mg

Sponsor

Korea Otsuka Pharmaceutical Co., Ltd.